Alcohol
Volume 34, Issue 1 , Pages 35-38 , August 2004

Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha

Received 30 March 2004 ,Revised 28 June 2004 ,Accepted 3 July 2004.

References 

  1. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, et al. Altered constitutive expression of fatty acid–metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem. 1998;273:5678–5684
  2. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem. 2000;275:16390–16399
  3. Bocos C, Göttlicher M, Gearing K, Banner C, Enmark E, Teboul M, et al. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J Steroid Biochem Mol Biol. 1995;53:467–473
  4. Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, et al. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis. 1997;18:669–674
  5. Cunard R, DiCampli D, Archer DC, Stevenson JL, Ricote M, Glass CK, et al. WY14,643, a PPARα ligand, has profound effects on immune responses in vivo. J Immunol. 2002;169:6806–6812
  6. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, et al. Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem. 1999;274:32048–32054
  7. Everett L, Galli A, Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver. 2000;20:191–199
  8. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem. 2003;278:27997–28004
  9. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem. 2001;276:68–75
  10. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem. 2000;275:28918–28928
  11. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology. 2003;38:123–132
  12. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650
  13. Kersten S, Seyduox J, Peters JM, Gonzales FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest. 1999;103:1489–1498
  14. Lawrence JW, Wollenberg GK, DeLuca JG. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. Carcinogenesis. 2001;22:381–386
  15. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 1999;96:7473–7478
  16. Ma X, Baraona E, Lieber CS. Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats. Hepatology. 1993;18:1247–1253
  17. Munday MR, Hemingway CJ. The regulation of acetyl-CoA carboxylase—a potential target for the action of hypolipidemic agents. Adv Enzyme Regul. 1999;39:205–234
  18. Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S, Ezaki O. Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem. 2002;277:9562–9569
  19. Pignon JP, Bailey NC, Baraona E, Lieber CS. Fatty acid-binding protein: a major contributor to the ethanol-induced increase in liver cytosolic proteins in the rat. Hepatology. 1987;7:865–871
  20. Rabinowitz JL, Staeffen J, Hall CL, Brand JG. A probable defect in the β-oxidation of lipids in rats fed alcohol for 6 months. Alcohol. 1991;8:241–246
  21. Rao MS, Papreddy K, Musunuri S, Okonkwo A. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats. In Vivo. 2002;16:145–152
  22. Spritz N, Lieber CS. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate. Proc Soc Exp Biol Med. 1966;121:147–149
  23. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P. PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br J Pharmacol. 2003;139:163–171
  24. Tsutsumi A, Takase S. Effect of fenofibrate on fatty liver in rats treated with alcohol. Alcohol Clin Exp Res. 2001;25:75S–79S
  25. Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gäbele E, et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol. 2002;168:2963–2969
  26. Wan Y-J, Morimoto M, Thurman RG, Bojes HK, French SW. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci. 1995;56:307–317
  27. Wan Y-JY, Cai Y, Li J, Yuan Q-X, French B, Gonzalez FJ, et al. Regulation of peroxisome proliferator activated receptor α–mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice. Hepatol Res. 2001;19:117–130
  28. Ye J-M, Iglesias MA, Watson DG, Ellis B, Wood L, Jensen PB, et al. PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab. 2003;284:E531–E540
  29. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002;277:29342–29347

PII: S0741-8329(04)00153-3

doi: 10.1016/j.alcohol.2004.07.005

Alcohol
Volume 34, Issue 1 , Pages 35-38 , August 2004